MedTrace Logo

Clinical Trial for High Intensity Laser Therapy (HILT) for Elbow Epicondylosis

NCT01992627 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2013-11-25

No results posted yet for this study

Summary

This study will determine the efficacy of High Intensity Laser Therapy (HILT) for the treatment of elbow epicondylosis

Conditions

  • Chronic Pain
  • Elbow Tenderness
  • Elbow Pain Upon Active Resistive Motion

Interventions

DEVICE

HILTERAPIA HIRO 3.0

High-intensity laser therapy (HILT), which involves higher-intensity laser radiation and which causes minor and slow light absorption by chromophores. This absorption is obtained not with concentrated light but with diffuse light in all directions (the scattering phenomenon), increasing the mitochondrial oxidative reaction and adenosine triphosphate, RNA, or DNA production (photochemistry effects) and resulting in the phenomenon of tissue stimulation called photobiology.

Sponsors & Collaborators

  • CM Chungmu Hospital

    lead OTHER

Principal Investigators

  • Paolo Alan B. Tabar, MD · CM Chungmu Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
35 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2013-12-31
Completion
2013-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01992627 on ClinicalTrials.gov